Symptom interval of osteosarcoma around the knee joint: an analysis of 82 patients of a single institute
H. Li MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorS. Zheng MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorW. Yu MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorW. Huang MD
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China
Search for more papers by this authorY. Yao MD
Director
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorCorresponding Author
Z. Shen MD
Vice Director
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Correspondence address: Zan Shen and Yuanjue Sun, Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China (e-mail: [email protected], [email protected]).Search for more papers by this authorCorresponding Author
Y. Sun MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Correspondence address: Zan Shen and Yuanjue Sun, Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China (e-mail: [email protected], [email protected]).Search for more papers by this authorH. Li MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorS. Zheng MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorW. Yu MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorW. Huang MD
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China
Search for more papers by this authorY. Yao MD
Director
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Search for more papers by this authorCorresponding Author
Z. Shen MD
Vice Director
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Correspondence address: Zan Shen and Yuanjue Sun, Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China (e-mail: [email protected], [email protected]).Search for more papers by this authorCorresponding Author
Y. Sun MD
Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Correspondence address: Zan Shen and Yuanjue Sun, Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China (e-mail: [email protected], [email protected]).Search for more papers by this authorAbstract
The time from first onset of symptoms or signs to a definitive diagnosis and initiation of treatment is defined as symptom interval (SI), the impact of SI on prognosis of patient with osteosarcoma (OS) remains unclear. A total medical records of 52 male and 30 female aged between 8 and 61 (median, 17) with OS around the knee joint were reviewed. Two components of SI, patient delay and professional delay were analysed. The median total SI was 2 months (range from 0.2 to 13.2 months). The median patient delay was 1.05 months (range from 0 to 12.5), and median professional delay was 0.45 months. Total SI and patient delay were not significantly different when patients were grouped by gender, age, tumour size and response to chemotherapy. Younger patients (<18 years) had shorter professional delay than older patients (≥18 years) (P = 0.02). Although there was a trend for longer time to lung metastasis in patients of SI <3 months, there was no significant difference compared with patients of SI ≥3 months (P = 0.15). In this study, younger patients had shorter professional delay than older patients. There was no significant correlation between SI and time to lung metastasis.
References
- Bacci G., Ferrari S., Longhi A., Mellano D., Giacomini S. & Forni C. (2000) Delay in diagnosis of high-grade osteosarcoma of the extremities. Has it any effect on the stage of disease? Tumori 86, 204–206.
- Bacci G., Mercuri M., Longhi A., Ferrari S., Bertoni F., Versari M. & Picci P. (2005) Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. European Journal of Cancer 41, 2079–2085.
- Bacci G., Longhi A., Versari M., Mercuri M., Briccoli A. & Picci P. (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106, 1154–1161.
- Bauer H.C., Trovik C.S., Alvegard T.A., Berlin O., Erlanson M., Gustafson P., Klepp R., Moller T.R., Rydholm A., Saeter G., Wahlstrom O. & Wiklund T. (2001) Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica 72, 150–159.
- Bentzen S.M., Poulsen H.S., Kaae S., Jensen O.M., Johansen H., Mouridsen H.T., Daugaard S. & Arnoldi C. (1988) Prognostic factors in osteosarcomas. A regression analysis. Cancer 62, 194–202.
10.1002/1097-0142(19880701)62:1<194::AID-CNCR2820620129>3.0.CO;2-8 CAS PubMed Web of Science® Google Scholar
- Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Werner M., Winkelmann W., Zoubek A., Jurgens H. & Winkler K. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Journal of Clinical Oncology 20, 776–790.
- Cecen E., Gunes D., Mutafoglu K., Sarialioglu F. & Olgun N. (2011) The time to diagnosis in childhood lymphomas and other solid tumors. Pediatric Blood and Cancer 57, 392–397.
- Dang-Tan T., Trottier H., Mery L.S., Morrison H.I., Barr R.D., Greenberg M.L. & Franco E.L. (2008) Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatric Blood and Cancer 51, 468–474.
- Elias A.D. (1998) High-dose therapy for adult soft tissue sarcoma: dose response and survival. Seminars in Oncology, 25, 19–23; discussion 45–18.
- Ferrari S., Bertoni F., Mercuri M., Picci P., Giacomini S., Longhi A. & Bacci G. (2001) Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Annals of Oncology 12, 1145–1150.
- Ferrari A., Miceli R., Casanova M., Meazza C., Favini F., Luksch R., Catania S., Fiore M., Morosi C. & Mariani L. (2010) The symptom interval in children and adolescents with soft tissue sarcomas. Cancer 116, 177–183.
- George A. & Grimer R. (2012) Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier? Annals of the Royal College of Surgeons of England 94, 261–266.
- Goyal S., Roscoe J., Ryder W.D., Gattamaneni H.R. & Eden T.O. (2004) Symptom interval in young people with bone cancer. European Journal of Cancer 40, 2280–2286.
- Grimer R.J. (2006) Size matters for sarcomas!. Annals of the Royal College of Surgeons of England 88, 519–524.
- Gronchi A., Lo Vullo S., Colombo C., Collini P., Stacchiotti S., Mariani L., Fiore M. & Casali P.G. (2010) Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Annals of Surgery 251, 506–511.
- Loh A.H., Ha C., Chua J.H., Seow W.T., Chan M.Y., Tan A.M. & Chui C.H. (2009) Delays in diagnosis of pediatric solid tumors in Singapore. Journal of Pediatric Hematology/Oncology 31, 734–738.
- Ottaviani G. & Jaffe N. (2009) The epidemiology of osteosarcoma. Cancer Treatment and Research 152, 3–13.
- Pan K.L., Chan W.H. & Chia Y.Y. (2010) Initial symptoms and delayed diagnosis of osteosarcoma around the knee joint. Journal of Orthopaedic Surgery 18, 55–57.
- Schnurr C., Pippan M., Stuetzer H., Delank K.S., Michael J.W. & Eysel P. (2008) Treatment delay of bone tumours, compilation of a sociodemographic risk profile: a retrospective study. BMC Cancer 8, 22.
- Smith G.M., Johnson G.D., Grimer R.J. & Wilson S. (2011) Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis. Annals of the Royal College of Surgeons of England 93, 542–547.
- Sneppen O. & Hansen L.M. (1984) Presenting symptoms and treatment delay in osteosarcoma and Ewing's sarcoma. Acta Radiologica. Oncology 23, 159–162.
- Weller D., Vedsted P., Rubin G., Walter F.M., Emery J., Scott S., Campbell C., Andersen R.S., Hamilton W., Olesen F., Rose P., Nafees S., van Rijswijk E., Hiom S., Muth C., Beyer M. & Neal R.D. (2012) The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. British Journal of Cancer 106, 1262–1267.
- Wurtz L.D., Peabody T.D. & Simon M.A. (1999) Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. The Journal of Bone and Joint Surgery. American Volume 81, 317–325.
- Yang J.Y., Cheng F.W., Wong K.C., Lee V., Leung W.K., Shing M.M., Kumta S.M. & Li C.K. (2009) Initial presentation and management of osteosarcoma, and its impact on disease outcome. Hong Kong Medical Journal 15, 434–439.